#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Cholangiocarcinoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Mitochondrial DNA depletion Pulmonary fibrosis Myelofibrosis Ovarian cancer stage IV Arterial disorder Langerhans cell sarcoma Cerebral haemorrhage Henoch-Schonlein purpura nephritis Hodgkin's disease refractory Uveitis Myeloid leukaemia Propionic acidaemia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Life with Disease Angelman’s syndrome – Basic Information CADASIL – Basic Information X-linked lymphoproliferative syndrome – Diagnostics Mucopolysaccharidosis II – Life with Disease Ehlers-Danlos syndrome – Treatment Krabbe’s disease – Basic Information Antithrombin III deficiency – Basic Information Adrenogenital syndrome – Trials in Disease Angiosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imatinib Mesilate GSKVX000000034797 Quinine Dihydrochloride Ferric Derisomaltose Zilovertamab Vedotin Amiodarone Hydrochloride Linagliptin Gsk4381562A Idursulfase Sodium Glycocholate Xp-Dc+Tl+Klh Bisoprolol Aminohippuric Acid Io103 Acetate Emraclidine Alanine Taurine Nipocalimab Cefazolin Sot102 More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Notalgia paraesthetica Mitral valve prolapse Psychological trauma Complicated appendicitis Undifferentiated sarcoma Liver transplant Type IIa hyperlipidaemia Endometrial cancer stage I Intestinal infarction Bladder cancer stage II Urticaria cholinergic Pruritus Pancreatic carcinoma stage IV Benign renal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac ablation

  • Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dronedarone
    • Sotalol
    Bulgaria Denmark Germany Hungary Norway Slovakia +1
  • Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolic stroke
    • Atrial fibrillation
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Rivaroxaban
    Belgium Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!